Keyword: Sanofi

News

Amgen Biosimilar Push Takes Aim at Blockbusters

07.02.2013 - Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...

News

Buyers Eye Multibillion Deal for Brazilian Drugmaker

07.02.2013 - International drug companies are considering bidding for Ache Laboratorios Farmaceuticos, one of Brazil's biggest drugmakers, in a deal valuing it at several billion dollars...

News

Patent Expiries Delay Sanofi's Return to Growth

07.02.2013 - French drugmaker Sanofi said earnings could fall this year as it continues to feel the effects of expiring patents, disappointing hopes of a return to growth. The group, which saw...

News

Drugmakers, Academics Pool R&D in $265 Million EU Project

07.02.2013 - Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...

News

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

01.02.2013 - Pfizer's animal health subsidiary Zoetis raised $2.2 billion in its public offering on Thursday, becoming the largest IPO from a U.S. company since Facebook. Madison, New Jersey...

News

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

26.01.2013 - Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a...

News

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

19.01.2013 - Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...

News

Roche Says US Allows it to Tap Adult Tamiflu Reserves

18.01.2013 - Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...